NCT06956976View on ClinicalTrials.gov

Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

1,596

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2031

Study Completion Date

June 1, 2031

Conditions
Rectal Cancer
Interventions
PROCEDURE

Dissection of Inferior Mesenteric Artery Root Lymph Node

Patients underwent robotic radical resection for rectal cancer, adhering to the principles of Total Mesorectal Excision (TME) or Tumor-Specific Mesorectal Excision (TSME), and dissecting the lymph nodes at the root of the inferior mesenteric artery (IMA).

PROCEDURE

Preservation of Inferior Mesenteric Artery Root Lymph Node

Patients underwent robotic radical resection for rectal cancer, adhering to the principles of Total Mesorectal Excision (TME) or Tumor-Specific Mesorectal Excision (TSME), but preserving the lymph nodes at the root of the inferior mesenteric artery (IMA).

Trial Locations (1)

200032

Zhongshan Hospital Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER